BNTX peer analysis
BioNTech (BNTX) against its competitors: price, today's move, 1-year return and market value side by side.
BNTX and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| CGEN Compugen | $1.98 | -2.94% | 20.00% | $187.56M |
| GMAB Genmab | $54.93 | -3.73% | 91.59% | $35.09B |
| IBRX ImmunityBio | $7.99 | -3.62% | 238.56% | $8.79B |
| IMCR Immunocore | $29.79 | -2.30% | -7.46% | – |
| IMTX Immatics | $7.20 | -1.50% | -30.90% | – |
| INCY Incyte | $119.99 | -0.33% | 29.59% | $24.54B |
| IOVA Iovance | $8.00 | -5.66% | 310.26% | $3.84B |
| MGNX MacroGenics | $2.40 | 0.84% | 50.47% | $152.88M |
| TGTX TG Therapeutics | $59.97 | -1.99% | 76.26% | $9.36B |
| XNCR Xencor | $29.68 | -0.47% | 110.05% | $2.22B |
| BNTX BioNTech | $87.49 | -0.77% | -16.41% | $22.15B |
- BNTX's peers: CGEN (Compugen), GMAB (Genmab), IBRX (ImmunityBio), IMCR (Immunocore), IMTX (Immatics), INCY (Incyte), IOVA (Iovance), MGNX (MacroGenics).
Updated 2026-11-02 23:14 UTC